FdaApplication
ANDA 215827
Identifiers
- fda_app_no: ANDA215827
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2023-02-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REGADENOSON | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION;INTRAVENOUS |
1 product